home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.30 +0.53 (+0.71%)

Streaming Delayed Price Updated: 1:38 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

49 50 Next >

DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

March 03, 2025

Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

3 Growth Stocks to Buy and Hold Forever ↗

March 01, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Dexcom Announces Upcoming Conference Presentation

February 27, 2025

From DexCom, Inc.

Via Business Wire

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

February 27, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...

Via StockStory

Topics Artificial Intelligence

DexCom Analysts Increase Their Forecasts After Q4 Earnings ↗

February 14, 2025

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

Should You Buy DexCom Stock Before Feb. 13? ↗

February 06, 2025

Via The Motley Fool

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

February 26, 2025

Via The Motley Fool

These S&P500 stocks are moving in today's pre-market session ↗

February 19, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Insulet Earnings: What To Look For From PODD

February 19, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Via StockStory

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

February 19, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

Via StockStory

What's going on in today's session: S&P500 movers ↗

February 14, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings) ↗

February 03, 2025

Via Benzinga

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom ↗

February 14, 2025

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

February 14, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Via Chartmill

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗

February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Via Benzinga

Topics Stocks

Discover which S&P500 stocks are making waves on Friday. ↗

February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More ↗

February 14, 2025

Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.

Via Benzinga

DexCom (DXCM) Q4 2024 Earnings Call Transcript ↗

February 13, 2025

DXCM earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

DexCom: Revenue Up, EPS Misses Mark ↗

February 13, 2025

DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.

Via The Motley Fool

DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue

February 13, 2025

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...

Via StockStory

Topics Artificial Intelligence

Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations ↗

February 13, 2025

Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.

Via Investor's Business Daily

Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results

February 13, 2025

From DexCom, Inc.

Via Business Wire

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

February 12, 2025

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.

Via StockStory

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

February 10, 2025

Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade ↗

February 03, 2025

Via The Motley Fool

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years ↗

February 03, 2025

Via The Motley Fool

For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗

January 31, 2025

NASDAQ:DXCM is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

January 30, 2025

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com